Major drug breakthrough to treat Alzheimer’s
A new drug called NitroMemantine has been found to boost brain synapses lost to Alzheimer’s disease. By combining two medicines that are already approved by the FDA, NitroMemantine restores the synapses between neurons. It’s the destruction of these synapses that leads to cognitive decline and memory loss.
In the past, drugs aimed to treat Alzheimer’s disease have addressed the amyloid beta plaques or neurofibrillary tangles – without much success.
But NitroMemantine brings the number of synapses back to normal within just a few months! (These tests are done on mice.) This may bring hope to not only early-stage Alzheimer’s patients, but also those who have experienced the disease’s progression.
http://www.sciencedaily.com/releases/2013/06/130617160849.htm
Related Posts
-
Pets may be linked to slower cognitive decline
Posted on Mar 24, 2022
-
Poor score on simple memory test may be linked to Alzheimer’s biomarkers
Posted on Mar 15, 2022
-
Hypertension in young adults affects brain later
Posted on Mar 8, 2022
-
Being lonely more often may raise dementia risk
Posted on Mar 3, 2022
Tags
Share This
